Todd Druley

Dr. Todd Druley currently serves as the Chief Medical Officer for ArcherDX, Inc. Dr. Druley completed a Bachelor’s in Cell and Structural Biology from the University of Illinois in 1994 and his M.D. and Ph.D. in Molecular Genetics at the University of Illinois in 2002. From there, he trained in pediatric oncology at Washington University in St. Louis. He established the first regional clinic for children with cancer predisposition as well as oversee the inpatient bone marrow transplant, oncology and hematology services. In 2009, he established a genomic laboratory focused on improving molecular diagnostics in cancer. With funding from the National Cancer Institute and multiple philanthropic organizations, the lab developed a track record of genomic innovation leading to novel physiologic and translational insights, most notably in the field of clonal hematopoiesis.

In 2019, Dr. Druley was inducted into the American Society of Clinical Investigators and serves as a member of the Scientific Advisory Boards for the B+ Foundation and the Kids Shouldn’t Have Cancer Foundation. At ArcherDX, Dr.Druley oversees a Medical Affairs program supporting clinical and translational research that applies new genomic technologies to improve the surveillance, treatment and outcomes of all cancer patients.